Reduction of streptavidin RYDS-mediated renal adhesion by site-directed mutagenesis

This publication has 24 references indexed in Scilit:

• Improving tumour targeting and decreasing normal tissue uptake by optimizing the stoichiometry of a two-step biotinylated-antibody/streptavidin-based targeting strategy: Studies in a nude mouse xenograft model
  International Journal of Cancer, 1998
• RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
  Annual Review of Cell and Developmental Biology, 1996
• Renal accumulation of streptavidin: Potential use for targeted therapy to the kidney
  Kidney International, 1995
• Construction and expression of a synthetic streptavidin-encoding gene in Escherichia coli
  Gene, 1993
• Streptavidin blocks immune reactions mediated by fibronectin‐VLA‐5 recognition through an Arg‐Gly‐Asp mimicking site
  European Journal of Immunology, 1993
• Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin
  European Journal of Nuclear Medicine and Molecular Imaging, 1992
• Streptavidin contains an RYD sequence which mimics the RGD receptor domain of fibronectin
  Biochemical and Biophysical Research Communications, 1990
• Intraperitoneal radio‐localization of tumors pre‐targeted by biotinylated monoclonal antibodies
  International Journal of Cancer, 1990
• Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.
  Proceedings of the National Academy of Sciences, 1984
• Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
  Nature, 1984